Advertisement
Screener

GILEAD SCIENCES, INC. (GILD) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

GILEAD SCIENCES, INC. Increase (Decrease) in Prepaid Expense and Other Assets

GILEAD SCIENCES, INC. (GILD) reported Increase (Decrease) in Prepaid Expense and Other Assets of $8.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06

  • GILEAD SCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $13.00M.
  • GILEAD SCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$5.00M.
  • GILEAD SCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $36.00M, a 75.34% decline year-over-year.
  • GILEAD SCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $368.00M, a 545.61% increase year-over-year.
  • GILEAD SCIENCES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $311.00M, a 20.08% increase from fiscal 2024.
  • GILEAD SCIENCES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $259.00M.
  • GILEAD SCIENCES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$39.00M, a 129.10% decline from fiscal 2022.
  • GILEAD SCIENCES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $134.00M, a 197.78% increase from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30$13.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$8.00M
10-Q · filed 2026-08-06
$44.00M
derived: sum of 3 quarters · filed 2026-08-06
$412.00M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$5.00M
10-Q · filed 2026-05-07
$31.00M
derived: sum of 2 quarters · filed 2026-05-07
$399.00M
derived: sum of 3 quarters · filed 2026-05-07
$318.00M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$36.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$404.00M
derived: sum of 2 quarters · filed 2026-02-24
$323.00M
derived: sum of 3 quarters · filed 2026-08-06
$311.00M
10-K · filed 2026-02-24
2025-09-30$368.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$287.00M
derived: sum of 2 quarters · filed 2026-08-06
$275.00M
10-Q · filed 2025-11-07
$421.00M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$81.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$93.00M
10-Q · filed 2026-08-06
$53.00M
derived: sum of 3 quarters · filed 2026-08-06
$110.00M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$12.00M
10-Q · filed 2026-05-07
$134.00M
derived: sum of 2 quarters · filed 2026-05-07
$191.00M
derived: sum of 3 quarters · filed 2026-05-07
$210.00M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$146.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$203.00M
derived: sum of 2 quarters · filed 2026-02-24
$222.00M
derived: sum of 3 quarters · filed 2026-02-24
$259.00M
10-K · filed 2026-02-24
2024-09-30$57.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$76.00M
derived: sum of 2 quarters · filed 2025-11-07
$113.00M
10-Q · filed 2025-11-07
$145.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30$19.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$56.00M
10-Q · filed 2025-08-07
$88.00M
derived: sum of 3 quarters · filed 2026-02-24
$83.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31$37.00M
10-Q · filed 2025-05-07
$69.00M
derived: sum of 2 quarters · filed 2026-02-24
$64.00M
derived: sum of 3 quarters · filed 2026-02-24
$24.00M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31$32.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$27.00M
derived: sum of 2 quarters · filed 2026-02-24
-$13.00M
derived: sum of 3 quarters · filed 2026-02-24
-$39.00M
10-K · filed 2026-02-24
2023-09-30-$5.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$45.00M
derived: sum of 2 quarters · filed 2024-11-12
-$71.00M
10-Q · filed 2024-11-12
-$6.00M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30-$40.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$66.00M
10-Q · filed 2024-08-08
-$1.00M
derived: sum of 3 quarters · filed 2025-02-28
-$13.00M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31-$26.00M
10-Q · filed 2024-05-08
$39.00M
derived: sum of 2 quarters · filed 2025-02-28
$27.00M
derived: sum of 3 quarters · filed 2025-02-28
$54.00M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31$65.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$53.00M
derived: sum of 2 quarters · filed 2025-02-28
$80.00M
derived: sum of 3 quarters · filed 2025-02-28
$134.00M
10-K · filed 2025-02-28
-$70.00M
10-K · filed 2023-02-22
2022-09-30-$12.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$15.00M
derived: sum of 2 quarters · filed 2023-11-07
$69.00M
10-Q · filed 2023-11-07
-$12.00M
10-Q · filed 2022-11-02
$97.00M
derived: sum of 4 quarters · filed 2024-02-23
2022-06-30$27.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
$81.00M
10-Q · filed 2023-08-04
$30.00M
10-Q · filed 2022-08-08
$109.00M
derived: sum of 3 quarters · filed 2024-02-23
$124.00M
derived: sum of 4 quarters · filed 2024-02-23
2022-03-31$54.00M
10-Q · filed 2023-05-03
$20.00M
10-Q · filed 2022-05-04
$82.00M
derived: sum of 2 quarters · filed 2024-02-23
$97.00M
derived: sum of 3 quarters · filed 2024-02-23
$91.00M
derived: sum of 4 quarters · filed 2024-02-23
2021-12-31$28.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23
$43.00M
derived: sum of 2 quarters · filed 2024-02-23
$37.00M
derived: sum of 3 quarters · filed 2024-02-23
$45.00M
10-K · filed 2024-02-23
$42.00M
10-K · filed 2022-02-23
2021-09-30$15.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
$9.00M
derived: sum of 2 quarters · filed 2022-11-02
$17.00M
10-Q · filed 2022-11-02
$253.00M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30-$6.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$2.00M
10-Q · filed 2022-08-08
$238.00M
derived: sum of 3 quarters · filed 2023-02-22
$292.00M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$8.00M
10-Q · filed 2022-05-04
$244.00M
derived: sum of 2 quarters · filed 2023-02-22
$298.00M
derived: sum of 3 quarters · filed 2023-02-22
$268.00M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31$236.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$290.00M
derived: sum of 2 quarters · filed 2023-02-22
$260.00M
derived: sum of 3 quarters · filed 2023-02-22
$214.00M
10-K · filed 2023-02-22
2020-09-30$54.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03
$24.00M
derived: sum of 2 quarters · filed 2021-11-03
-$22.00M
10-Q · filed 2021-11-03
$60.00M
derived: sum of 4 quarters · filed 2022-02-23
2020-06-30-$30.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
-$76.00M
10-Q · filed 2021-08-05
$6.00M
derived: sum of 3 quarters · filed 2022-02-23
$197.00M
derived: sum of 4 quarters · filed 2022-02-23
2020-03-31-$46.00M
10-Q · filed 2021-05-06
$36.00M
derived: sum of 2 quarters · filed 2022-02-23
$227.00M
derived: sum of 3 quarters · filed 2022-02-23
$218.00M
derived: sum of 4 quarters · filed 2022-02-23
2019-12-31$82.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
$273.00M
derived: sum of 2 quarters · filed 2022-02-23
$264.00M
derived: sum of 3 quarters · filed 2022-02-23
$307.00M
10-K · filed 2022-02-23
2019-09-30$191.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04
$182.00M
derived: sum of 2 quarters · filed 2020-11-04
$225.00M
10-Q · filed 2020-11-04
$71.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$9.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$34.00M
10-Q · filed 2020-08-06
-$120.00M
derived: sum of 3 quarters · filed 2021-02-25
-$247.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$43.00M
10-Q · filed 2020-05-06
-$111.00M
derived: sum of 2 quarters · filed 2021-02-25
-$238.00M
derived: sum of 3 quarters · filed 2021-02-25
-$331.00M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$154.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$281.00M
derived: sum of 2 quarters · filed 2021-02-25
-$374.00M
derived: sum of 3 quarters · filed 2021-02-25
-$903.00M
10-K · filed 2021-02-25
2018-09-30-$127.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
-$220.00M
derived: sum of 2 quarters · filed 2019-11-05
-$749.00M
10-Q · filed 2019-11-05
-$796.00M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30-$93.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
-$622.00M
10-Q · filed 2019-08-06
-$669.00M
derived: sum of 3 quarters · filed 2020-02-25
-$835.00M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31-$529.00M
10-Q · filed 2019-05-08
-$576.00M
derived: sum of 2 quarters · filed 2020-02-25
-$742.00M
derived: sum of 3 quarters · filed 2020-02-25
-$710.00M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31-$47.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
-$213.00M
derived: sum of 2 quarters · filed 2020-02-25
-$181.00M
derived: sum of 3 quarters · filed 2020-02-25
-$358.00M
10-K · filed 2020-02-25
2017-09-30-$166.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
-$134.00M
derived: sum of 2 quarters · filed 2018-11-06
-$311.00M
10-Q · filed 2018-11-06
-$576.00M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30$32.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06
-$145.00M
10-Q · filed 2018-08-06
-$410.00M
derived: sum of 3 quarters · filed 2019-02-26
$40.00M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31-$177.00M
10-Q · filed 2018-05-09
-$442.00M
derived: sum of 2 quarters · filed 2019-02-26
$8.00M
derived: sum of 3 quarters · filed 2019-02-26
$217.00M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31-$265.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$185.00M
derived: sum of 2 quarters · filed 2019-02-26
$394.00M
derived: sum of 3 quarters · filed 2019-02-26
$520.00M
10-K · filed 2019-02-26
2016-09-30$450.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$659.00M
derived: sum of 2 quarters · filed 2017-11-07
$785.00M
10-Q · filed 2017-11-07
$708.00M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$209.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07
$335.00M
10-Q · filed 2017-08-07
$258.00M
derived: sum of 3 quarters · filed 2018-02-27
$298.00M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$126.00M
10-Q · filed 2017-05-10
$49.00M
derived: sum of 2 quarters · filed 2018-02-27
$89.00M
derived: sum of 3 quarters · filed 2018-02-27
$268.00M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31-$77.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
-$37.00M
derived: sum of 2 quarters · filed 2018-02-27
$142.00M
derived: sum of 3 quarters · filed 2018-02-27
$90.00M
10-K · filed 2018-02-27
2015-09-30$40.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
$219.00M
derived: sum of 2 quarters · filed 2016-11-07
$167.00M
10-Q · filed 2016-11-07
$109.00M
derived: sum of 4 quarters · filed 2017-02-27
2015-06-30$179.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
$127.00M
10-Q · filed 2016-08-05
$69.00M
derived: sum of 3 quarters · filed 2017-02-27
-$24.00M
derived: sum of 4 quarters · filed 2017-02-27
2015-03-31-$52.00M
10-Q · filed 2016-05-06
-$110.00M
derived: sum of 2 quarters · filed 2017-02-27
-$203.00M
derived: sum of 3 quarters · filed 2017-02-27
$150.00M
derived: sum of 4 quarters · filed 2017-02-27
2014-12-31-$58.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
-$151.00M
derived: sum of 2 quarters · filed 2017-02-27
$202.00M
derived: sum of 3 quarters · filed 2017-02-27
$371.00M
10-K · filed 2017-02-27
2014-09-30-$93.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
$260.00M
derived: sum of 2 quarters · filed 2015-11-04
$429.00M
10-Q · filed 2015-11-04
$428.97M
10-Q · filed 2014-11-05
$487.80M
derived: sum of 4 quarters · filed 2016-02-24
2014-06-30$353.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05
$522.00M
10-Q · filed 2015-08-05
$521.75M
10-Q · filed 2014-08-04
$580.80M
derived: sum of 3 quarters · filed 2016-02-24
$538.20M
derived: sum of 4 quarters · filed 2016-02-24
2014-03-31$169.00M
10-Q · filed 2015-05-08
$169.38M
10-Q · filed 2014-05-07
$227.80M
derived: sum of 2 quarters · filed 2016-02-24
$185.20M
derived: sum of 3 quarters · filed 2016-02-24
$151.70M
derived: sum of 4 quarters · filed 2016-02-24
2013-12-31$58.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24
$16.20M
derived: sum of 2 quarters · filed 2016-02-24
-$17.30M
derived: sum of 3 quarters · filed 2016-02-24
$170.00M
10-K · filed 2016-02-24
$170.35M
10-K · filed 2014-02-25
2013-09-30-$42.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05
-$76.11M
derived: sum of 2 quarters · filed 2014-11-05
$111.20M
10-Q · filed 2014-11-05
$130.65M
derived: sum of 4 quarters · filed 2015-02-25
2013-06-30-$33.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04
$153.80M
10-Q · filed 2014-08-04
$173.25M
derived: sum of 3 quarters · filed 2015-02-25
$250.47M
derived: sum of 4 quarters · filed 2015-02-25
2013-03-31$187.30M
10-Q · filed 2014-05-07
$206.75M
derived: sum of 2 quarters · filed 2015-02-25
$283.98M
derived: sum of 3 quarters · filed 2015-02-25
$241.13M
derived: sum of 4 quarters · filed 2015-02-25
2012-12-31$19.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25
$96.67M
derived: sum of 2 quarters · filed 2015-02-25
$53.82M
derived: sum of 3 quarters · filed 2015-02-25
$129.00M
10-K · filed 2015-02-25
$129.32M
10-K · filed 2013-02-27
2012-09-30$77.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31
$34.37M
derived: sum of 2 quarters · filed 2013-10-31
$109.55M
10-Q · filed 2013-10-31
$136.88M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30-$42.85M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01
$32.33M
10-Q · filed 2013-08-01
$59.66M
derived: sum of 3 quarters · filed 2014-02-25
$57.17M
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31$75.18M
10-Q · filed 2013-05-08
$102.51M
derived: sum of 2 quarters · filed 2014-02-25
$100.02M
derived: sum of 3 quarters · filed 2014-02-25
$65.23M
derived: sum of 4 quarters · filed 2014-02-25
2011-12-31$27.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$24.84M
derived: sum of 2 quarters · filed 2014-02-25
-$9.94M
derived: sum of 3 quarters · filed 2014-02-25
$13.96M
10-K · filed 2014-02-25
2011-09-30-$2.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06
-$37.28M
derived: sum of 2 quarters · filed 2012-11-06
-$13.37M
10-Q · filed 2012-11-06
$51.27M
derived: sum of 4 quarters · filed 2013-02-27
2011-06-30-$34.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01
-$10.88M
10-Q · filed 2012-08-01
$53.76M
derived: sum of 3 quarters · filed 2013-02-27
$59.88M
derived: sum of 4 quarters · filed 2013-02-27
2011-03-31$23.90M
10-Q · filed 2012-05-04
$88.55M
derived: sum of 2 quarters · filed 2013-02-27
$94.67M
derived: sum of 3 quarters · filed 2013-02-27
$100.67M
derived: sum of 4 quarters · filed 2013-02-27
2010-12-31$64.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
$70.77M
derived: sum of 2 quarters · filed 2013-02-27
$76.77M
derived: sum of 3 quarters · filed 2013-02-27
$70.47M
10-K · filed 2013-02-27
2010-09-30$6.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
$12.12M
derived: sum of 2 quarters · filed 2011-11-04
$5.82M
10-Q · filed 2011-11-04
$38.13M
derived: sum of 4 quarters · filed 2012-02-23
2010-06-30$6.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05
-$299.00K
10-Q · filed 2011-08-05
$32.01M
derived: sum of 3 quarters · filed 2012-02-23
$75.97M
derived: sum of 4 quarters · filed 2012-02-23
2010-03-31-$6.30M
10-Q · filed 2011-05-09
$26.01M
derived: sum of 2 quarters · filed 2012-02-23
$69.96M
derived: sum of 3 quarters · filed 2012-02-23
$59.26M
derived: sum of 4 quarters · filed 2012-02-23
2009-12-31$32.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23
$76.27M
derived: sum of 2 quarters · filed 2012-02-23
$65.56M
derived: sum of 3 quarters · filed 2012-02-23
$65.67M
10-K · filed 2012-02-23
2009-09-30$43.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08
$33.25M
derived: sum of 2 quarters · filed 2010-11-08
$33.36M
10-Q · filed 2010-11-08
$1.36M
derived: sum of 4 quarters · filed 2011-02-28
2009-06-30-$10.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09
-$10.60M
10-Q · filed 2010-08-09
-$42.59M
derived: sum of 3 quarters · filed 2011-02-28
-$17.31M
derived: sum of 4 quarters · filed 2011-02-28
2009-03-31$102.00K
10-Q · filed 2010-05-10
-$31.89M
derived: sum of 2 quarters · filed 2011-02-28
-$6.61M
derived: sum of 3 quarters · filed 2011-02-28
2008-12-31-$31.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28
-$6.71M
derived: sum of 2 quarters · filed 2011-02-28
-$9.72M
10-K · filed 2011-02-28
2008-09-30$25.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05
$22.27M
10-Q · filed 2009-11-05
2008-06-30-$3.00M
10-Q · filed 2009-08-05
2007-12-31$252.49M
10-K · filed 2010-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMGEN INC (AMGN)United States$219.567B22.39
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31